xanthinol niacinate has been researched along with Intermittent Claudication in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Majorana, M; Spinella, G | 1 |
Davis, E; Rozov, H | 1 |
Cameli, AM; Dorigo, D; Mazzotta, A; Negro, P; Raspanti, D; Trapani, M | 1 |
Gómez Reyes, D; Rojas Hidalgo, E | 2 |
2 trial(s) available for xanthinol niacinate and Intermittent Claudication
Article | Year |
---|---|
[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Propanolamines; Random Allocation; Suloctidil; Theophylline; Time Factors; Xanthinol Niacinate | 1983 |
Xanthinol nicotinate in peripheral vascular disease.
Topics: Adult; Aged; Blood Viscosity; Capillary Fragility; Cholesterol; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Humans; Intermittent Claudication; Male; Middle Aged; Oscillometry; Skin Temperature; Theophylline; Vascular Diseases; Xanthinol Niacinate | 1975 |
3 other study(ies) available for xanthinol niacinate and Intermittent Claudication
Article | Year |
---|---|
[Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Topics: Arterial Occlusive Diseases; Drug Evaluation; Follow-Up Studies; Humans; Intermittent Claudication; Leg; Male; Moxisylyte; Theophylline; Xanthinol Niacinate | 1987 |
[Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Topics: Adult; Aged; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Male; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1988 |
[Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
Topics: Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Intermittent Claudication; Pentoxifylline; Theophylline; Xanthinol Niacinate | 1986 |